Opthea Ltd: Results of Meeting
Opthea Ltd: Director Appointment/Resignation
Opthea Ltd: Chair's Address to Shareholders
Opthea Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Opthea Ltd: Opthea Corporate Presentation - Oct 2024
Opthea Ltd: Notice of Annual General Meeting/Proxy Form
Opthea Ltd: Opthea Files Notice of Annual General Meeting
Opthea Ltd: Opthea EURetina Symposium 2024
Opthea Ltd: Opthea Corporate Presentation - September 2024
Opthea Ltd: Opthea A$55.0m (US$36.9m) Retail Entitlement Offer Opens
Opthea Ltd: Opthea Equity Raise Investor Presentation
Opthea Ltd: Opthea Corporate Presentation - April 2024
Opthea Ltd: Opthea Appoints Sujal Shah to the Board of Directors
Opthea Ltd: Opthea Key Opinion Leader Even on Sozinibercept
Opthea Ltd: Opthea Corporate Presentation - March 2024
Opthea Ltd: Results of Meeting
Opthea Ltd: Notice of Annual General Meeting/Proxy Form
Opthea Ltd: Opthea Appoints U.S. Based Leadership
Opthea Ltd: Opthea Retail Entitlement Offer Opens
Opthea Ltd: ASRS 2023 - PK and safety of sozinibercept (OPT-302)
No Data
No Data